Recurrent thrombosis rescued by fondaparinux in high‐risk patients: A case series

BACKGROUND: Recurrent thrombosis treatment options are limited when anticoagulation with dose escalation of low molecular weight heparin or unfractionated heparin fail. Fondaparinux is a pure, synthetic pentasaccharide that consists of heparin's essential five‐sugar chain that binds antithrombi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanguay, Mégane, Séguin, Chantal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336207/
https://www.ncbi.nlm.nih.gov/pubmed/35919877
http://dx.doi.org/10.1002/rth2.12773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336207/
https://www.ncbi.nlm.nih.gov/pubmed/35919877
http://dx.doi.org/10.1002/rth2.12773

Ejemplares similares